BMI Effect on the Response to Ovulation Induction in Letrozole vs Clomid

Status Not yet recruiting

Clinical Trial Summary

There is an increased prevalence of high Body mass index (BMI) all over the world.High BMI is shown to have an impact on the female reproductive system.It can contribute to both ovulatory and anovulatory subfertility.

Clomiphene citrate and Letrozole have been used for treatment of infertility.Both are used for induction of ovulation.

Clomiphene citrate is an estrogen receptor antagonist .It increases serum FSH and it has its limitation due to his antiestrogenic effect,it has an ovulation rate 70-80% but pregnancy rate is only 22% because of its anti-estrogenic effect on endometrium and poor cervical mucus (Legro RS et al.,2007) Letrozole is an aromatase inhibitor which inhibits the production of estrogen, which influences the action of the brain's hypothalamus and pituitary on the functioning of the ovaries by increasing FSH.Due to the antiestrogenic effect of clomiphene citrate,Letrozole can be used as an alternative.

The investigators are comparing the effect of both medications on the outcome of the induction of ovulation in women with high BMI.

Clinical Trial Description

This is a Randomized controlled trial .The researchers include160 women with BMI more than 30 who were suffering from subfertility for more than 2 years. The investigators will randomise them into 2 groups. Group A:They were prescribed 100 mg of clomiphene citrate from day 2-5 of the cycle for 5 days. Group B : They were prescribed 5 mg of Letrozole from day 2-5 of the cycle.

Vaginal ultrasound was performed on day 11 of the cycle, After at least one follicle reached 15 mm, The patient was encouraged to have sexual intercourse every other day for few days.The patients will have a midluteal progesterone level to confirm ovulation and will have a pregnancy test in 2 weeks if missed period. The researchers will compare the number of mature follicles, endometrial thickness on the day when there are mature follicles, occurrence of pregnancy, multiple pregnancies, and miscarriages . ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04331197
Study type	Interventional
Source	Cairo University
Contact	Eman Elkattan, MD,MRCOG,DFSRH
Phone	01212529213
Email	emyelkattan@gmail.com
Status	Not yet recruiting
Phase	Phase 4
Start date	May 1, 2020
Completion date	June 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03569787` - Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
Completed	`NCT03105453` - The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)
Terminated	`NCT02180256` - Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial	N/A
Terminated	`NCT02197832` - A RCT on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing FET Cycles	N/A
Completed	`NCT00971152` - Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle	Phase 3
Completed	`NCT01569945` - Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur	N/A
Recruiting	`NCT04064840` - GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET	Phase 3
Recruiting	`NCT02561793` - DHEA Versus Placebo in Women With Poor Ovarian Response	Phase 3
Terminated	`NCT02570386` - Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer	N/A
Completed	`NCT02197208` - A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET	N/A
Completed	`NCT01961336` - Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF	Phase 3
Completed	`NCT02487940` - Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure	Phase 4
Completed	`NCT01385618` - Gene-polymorphisms Relating to Human Subfertility	N/A
Completed	`NCT00985062` - Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization	N/A
Recruiting	`NCT04538560` - Preimplantation Genetic Testing for Aneuploidy of Polar Bodies	N/A
Completed	`NCT02748278` - Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment
Completed	`NCT02044445` - Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?	N/A
Completed	`NCT02863614` - Analgesia for Endometrial Scratching	N/A
Completed	`NCT02151006` - Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?	Phase 3
Completed	`NCT02154958` - Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.